Pfizer image

Torisel-Avastin combo fails in kidney cancer

August 13, 2012
Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …

Lucentis image

Lucentis gains new licence in the US

August 13, 2012
Sales and Marketing Eylea, FDA, Lucentis, approval, avastin, wet AMD

Roche’s eye drug Lucentis has gained a new licence in the US to treat diabetic macular oedema. The FDA has …

Contract research news in brief

August 10, 2012
Research and Development Accenture, Charles River Labs, ICON, Octagon Research Solutions, Phlexglobal, Quanticate, Verum

ICON plans UK investment, Verum expands in the US, plus updates from Charles River, Phlexglobal, Accenture/Octagon and Quanticate.

merck serono image

Merck Serono says dispute over Geneva closure is resolved

August 10, 2012
Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts

Merck Serono says it has reached agreement with groups representing workers affected by the closure and downsizing of sites in …

FDA image

FDA approves leukaemia drug Marqibo

August 10, 2012
Sales and Marketing FDA, Marqibo, Talon Therapeutics, lilly

The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of …

Pfizer signs drug profiling deal with Nodality

August 10, 2012
Research and Development, Sales and Marketing Lupus, Nodality, Pfizer, SCNP

Pfizer has signed a multi-year drug profiling deal with Nodality to help get the best from its autoimmune disease compounds. …

screen_shot_2012-08-10_at_10

Former Pfizer head Kindler joins Lux Capital

August 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kindler, Pfizer

Venture capital firm Lux Capital has appointed former Pfizer chairman and chief executive Jeff Kindler as a partner. Kindler will …

Fuji buys Thai manufacturing facility from DKSH

August 9, 2012
Manufacturing and Production DKSH, Fuji, OLIC, Thai

Japan’s Fuji Pharma has bought Thailand’s largest pharmaceutical contract manufacturing organisation OLIC from current owner DKSH. In a deal that …

Amanda Paxon image

Working Life: Amanda Paxon

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amanda Paxon, Boehringer Ingelheim, Working Life

 How did you find your way into your current role? Through a combination of good luck and hard work! I …

Zelboraf image

NICE still minded not to recommend Zelboraf

August 9, 2012
Sales and Marketing BMS, NICE, QALY, Yervoy, Zelboraf

NICE is asking Roche for more information about its melanoma pill Zelboraf, saying it is still too expensive and its …

Amgen scraps pancreatic cancer drug

August 9, 2012
Research and Development, Sales and Marketing Amgen, GAMMA, Ganitumab, pancreatic

Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …

Nicholson image

Nicholson to end NHS black listing of drugs

August 9, 2012
Sales and Marketing IHW, NHS, NICE, Sir David Nicholson, formulary

The chief executive of the NHS is looking to stamp out black listing of NICE-approved medicines. In a letter to …

Cambridge University gains stem cell centre funding

August 9, 2012
Research and Development, Sales and Marketing Cambridge, MRC, Wellcome Trust, stem cell

The Wellcome Trust and the Medical Research Council are investing £8 million into a new stem cell research centre. The …

David Willetts image

UK government to create four new ‘eHealth’ centres

August 9, 2012
Sales and Marketing MRC, NHS, data, eHealth, investment, patient records

A consortium of ten UK government and charity groups has invested £19 million to create a series of eHealth research …

screen_shot_2012-08-09_at_11

NHS Board appointments

August 9, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS, government

Further Commissioning Support Unit (CSU) managing directors have been announced by the NHS Board Authority.

UK doctors must prepare for the rise of the ‘ePatient’

August 9, 2012
Medical Communications, Sales and Marketing ABPI, GPs, digital

Doctors and other healthcare professionals must prepare for the rise of ‘ePatients’ in the coming years and keep apace with …

screen_shot_2012-08-08_at_16

ABPI appoints UK pharma team to head VBP discussion

August 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, VBP

The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the …

Pfizer pays $60m in bribery cases

August 8, 2012
Sales and Marketing DoJ, FDA, GSK, Janssen, Pfizer, Wyeth, bribery

Pfizer has been fined $60 million for making improper payments to doctors in Europe, Asia and the Middle East. The …

Astrazeneca image

AstraZeneca and BTG sepsis drug fails

August 8, 2012
Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis

AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …

charles-howeson

Appointments made to NHS property services

August 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Howeson, NHS

The company set up by the government to manage all the ex-PCT estate not transferred to providers (NHS Property Services), …

The Gateway to Local Adoption Series

Latest content